News

BrightInsight, a provider of a global regulated digital health platform for biopharma and medtech, has secured $101 million in Series C financing.

6sense, an account engagement platform, has raised $125 million in Series D funding.

AffaMed Therapeutics, a global clinical-stage biopharmaceutical company, has raised over $170 million in Series B financing.

Palo Alto, California-based Immune-Onc, a cancer immunotherapy company, has secured $73 million in Series B1 and B2 financing.

Recuro Health, a provider of digital health solutions, has secured an undisclosed amount of funding.

INBRAIN Neuroelectronics, a medical device firm, has secured $16.8 million in Series A funding.

Capitolis, a SaaS platform that drives financial resource optimization for capital markets, has raised $90 million in Series C funding.

Pyxis Oncology, a provider of biologics, has secured $152 million in Series B financing.

Ecovative, a mycelium technology company, has raised $60 million in Series D funding.

Toronto-based Second Closet, a technology-enabled self-storage company, has raised C$20 million in financing, bringing total funding to C$35.2 million.